AnaptysBio
ANAB
124 hedge funds and large institutions have $1.77B invested in AnaptysBio in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 61 increasing their positions, 33 reducing their positions, and 29 closing their positions.
85% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 33
3.73% more ownership
Funds ownership: 102.24% → 105.96% (+3.7%)
7% less funds holding
Funds holding: 134 → 124 (-10)
30% less capital invested
Capital invested by funds: $2.53B → $1.77B (-$768M)
31% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 29
57% less funds holding in top 10
Funds holding in top 10: 7 → 3 (-4)
57% less call options, than puts
Call options by funds: $6.74M | Put options by funds: $15.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$74M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$44.6M |
| 3 |
State Street
Boston,
Massachusetts
|
+$28.8M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$24.2M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$19.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Frazier Management
Seattle,
Washington
|
-$115M |
| 2 |
PA
Perceptive Advisors
New York
|
-$24.7M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$21.7M |
| 4 |
DM
Deerfield Management
New York
|
-$19.4M |
| 5 |
VMI
VHCP Management II
New York
|
-$18.8M |
ANAB Hedge Fund Activity: Q2 2018 in Review
124 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q2 2018, worth a combined $1.77B — down 30% from $2.53B a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of ANAB and 20 opened new positions — a net loss of 9 holders — while 33 trimmed existing stakes and 61 added.
The largest buyer was Janus Henderson Group, adding an estimated $74M. The largest seller was Frazier Management, cutting an estimated $115M.
- 124 institutional investors held AnaptysBio (ANAB) as of Q2 2018, down from 134 in Q1 2018.
- Funds reported $1.77B of AnaptysBio stock for Q2 2018, down 30% quarter-over-quarter.
- 20 funds opened new AnaptysBio positions in Q2 2018 and 29 closed out, a net change of -9 holders.
- The largest AnaptysBio buyer in Q2 2018 was Janus Henderson Group, an estimated $74M added.
- The largest AnaptysBio seller in Q2 2018 was Frazier Management, an estimated $115M sold.
Based on aggregated 13F filings for Q2 2018.